focus -WSS

focus

author：Wikipedia 2025-09-03 03:19:39 - browse：889

CDC campus exterior -- first opinion coverage from STAT — ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Think you might have Covid

hotspot

WSS

How to increase colonoscopy rates? Looks like an AI can help

ASCO: Palliative care found as helpful given virtually as in person

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Elizabeth Holmes banned from government health programs

Parkinson’s finding may lead to tests and, someday, treatments

HIV drugs protect against transmission, even in unprotected sex

hotspot

focus

hotspot

Medicare details structure of new drug price negotiation program

NIH director takes cautious approach to Biden drug pricing priority

Activists slam private health insurers over coverage restrictions

ASCO: AstraZeneca says CAR

In Memoriam: Notable people who died in 2023

Francis Collins on trust in science and how Covid communications failed

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Wildfire smoke exposes gaps in outdoor worker protections

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

hotspot

Humana cuts profit projections as Medicare Advantage costs soar

See how much Covid

Humana cuts profit projections as Medicare Advantage costs soar

Dewpoint Therapeutics lays off staff after losing partnerships

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

eGenesis tests gene

knowledge

hotspot

Wikipedia

explore